Where Epidemiologists are Leaning on Kids Returning to School
A recent New York Times Upshot article offers comments from 133 epidemiologists on the matter of children returning to school [...]
Report: World ‘on the Precipice of a New Age of Medicine’
As the COVID-19 pandemic spurs a greater desire for more robust data, the "world is on the precipice of a [...]
Article: U.S. Should Scrap Specialty Drug Label
The U.S. should abandon the specialty-drug label for high-cost drugs and follow suit with other countries that categorize drugs by [...]
ISPOR Conducting Survey Regarding OSMs
An International Society for Pharmacoeconomics and Outcomes Research (ISPOR) special interest group is conducting a survey to gauge opinions on [...]
Report: Drugmakers Engaging in ‘Science by Press Release’
Drugmakers are increasingly taking up a tactic to make their experimental products stand out, according to a Politico report: "science [...]
Pink Sheet Analysis Spotlights COVID-19 Article Debacle
A recent analysis by the Pink Sheet looks at how the retraction of Lancet and New England Journal of Medicine [...]
ICER Plans Review of Treatments for High Cholesterol
The Institute for Clinical and Economic Review (ICER) announced plans to review Novartis' inclisiran and Esperion Therapeutics' Nexletol for the [...]
Phesi President Talks Impact of Pandemic on Trials, Supports Data-Driven Approach
Phesi Founder and President Gen Li in a recent interview with Outsourcing-Pharma discussed how the COVID-19 pandemic is affecting clinical [...]
Pfizer CEO Says No ‘Huge Price’ Tag on Vaccine
Pfizer CEO Albert Bourla vowed the company would not "go huge prices" on a coronavirus vaccine, Axios reports. "If we [...]
ICER to CF Community: ‘We Support Actions to Receive Fair Prices’
The Institute for Clinical and Economic Review (ICER) in a letter to the cystic fibrosis community says it supports fair [...]
Abt Associates-led Team Wins $28.8 Million Contract
An Abt Associates-led team was recently awarded a $28.8 million two-year contract to study COVID-19 transmission. Abt Associates in an [...]
Startup PatientPing Secures $60 Million in Funding
PatientPing, a Boston-based startup, secured a $60 million round of funding co-led by Andreessen Horowitz, F-Prime Capital, GV and Transformation [...]
How Can Pharma Best Interact with ICER?
A new report from FirstWord looks at how pharma can best engage with the Institute for Clinical and Economic Review [...]
511 Epidemiologists’ Forecast on Common Activities
A recent New York Times Upshot article offers insight into when hundreds of epidemiologists expect they'll resume 20 common activities [...]
IQVIA to Host Virtual Conference
IQVIA is set to host a free, virtual conference focused on real-world evidence June 25. The event is scheduled to [...]
Report: Hospitals Paid CEO Millions While Laying Off Thousands
Despite having received billions in emergency funds through the CARES Act, some of the nation's top hospital systems have been [...]
AMCP Nexus 2020 Registration Opens
Registration for AMCP Nexus 2020, which is set to kick off Oct. 20 in Las Vegas, is now open. AMCP [...]
Panel Discusses Financing of Transformative Therapies
A panel discussion offers multiple perspectives into the requirements and challenges involved with value-based contracting models for transformative therapies. The [...]
Using AI, NLP and Data Visualization with RWE to Generate Insights into Care Gaps: Retrospective Cohort Analysis of Fracture Risk in Patients with Osteopenia and Osteoporosis
Sponsored by Veradigm Real world data (RWD) are being used by an increasingly diverse group of stakeholders. As an example, [...]
Article: Where’s the Big Data for COVID-19?
Without a central database of key COVID-19 data, getting a leg up on the virus will prove a significant challenge, [...]
Report Suggests COVID-19 Could Cost Insurers up to $547 Billion
A new report from Wakely, commissioned by America's Health Insurance Plans (AHIP), suggests COVID-19 could cost payers between $30 [...]
Cytel Releases New Primer, Ebook on Synthetic Control Arms
Cytel has released a new ebook outlining the use cases and benefits of synthetic control arms in clinical trial settings, [...]
OptumRx: Payers Should Monitor Three Key Drugs
OptumRx in its latest drug pipeline update recommends payers to keep an eye on risdiplam, viltolarsen and trodelvy, FierceHealthcare reports. [...]
Digital Transformation: Shaping the Future of Market Access
In the final part of her series on digital transformation in market access, Dr. Patti Peeples, CEO of HealthEconomics.com, and [...]
AHIP: Uncertainty Hits Rate Setting Process
America's Health Insurance Plans (AHIP) says the COVID-19 pandemic has generated much uncertainty in the rate setting process for 2021, [...]